| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 6 | |
| #2 | United States | 4 | |
| #3 | EPO (European Patent Office) | 3 | |
| #4 | Canada | 1 | |
| #5 | China | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Biotechnology | |
| #4 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Heterocyclic compounds | |
| #4 | Acyclic or carbocyclic compounds | |
| #5 | Sugars | |
| #6 | Peptides | |
| #7 | Special acyclic compounds | |
| #8 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Hilfinger John | 8 |
| #2 | Shen Wei | 6 |
| #3 | Sherman Lizbeth B | 4 |
| #4 | Amidon Gordon L | 4 |
| #5 | Simon Eric | 3 |
| #6 | Gan Xinmin | 3 |
| #7 | Leesman Glen D | 3 |
| #8 | Lipka Elke D | 3 |
| #9 | Hutchings Kim M | 2 |
| #10 | White Andy D | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020006050A1 | Metabolically stable prodrugs | |
| WO2011123856A1 | Neuraminidase inhibitors | |
| WO2009129305A2 | Prodrugs of neuraminidase inhibitors | |
| WO2008121941A1 | Prodrugs of triciribine and triciribine phosphate | |
| WO2007112348A2 | Prodrug composition | |
| US2005208140A1 | Short peptide carrier system for cellular delivery of agent | |
| US5569452A | Pharmaceutical formulation having enhanced bile acid binding affinity | |
| US5387421A | Multi stage drug delivery system | |
| EP0695174A1 | Multi-stage drug delivery system |